SlideShare a Scribd company logo
1 of 30
A Top 20 Pharma’s Journey to
Perpetual Inspection Readiness
2Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Sarah O’Hora
Director Vault Clinical
Rick Ward
VP, Commercial Operations
Leading Today’s Discussion
3Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Discussion Agenda
• Defining a few key terms:
− “Comprehensive Training Records”
− “Active TMF Management“
− “Inspection Readiness”
• Top 20 Pharma: Journey to Perpetual Inspection Readiness
− Centralizing Training Records Management
− Automating Processes
− Integrating with eTMF
Defining a Few Key Terms
“Comprehensive
Training Records”
6Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
ICH GCP E6 (R2)
Section 4.1: Investigator’s Qualification
and Agreements
• “The investigator(s) should be
qualified by education, training,
and experience to assume
responsibility for the proper
conduct of the trial, should meet
all the qualifications specified by
the applicable regulatory
requirement(s), and should
provide evidence of such
qualifications through up-to-date
curriculum vitae and/or other
relevant documentation
requested by the sponsor, the
IRB/IEC, and/or the regulatory
authority(ies).”
Section 5.6: Investigator Selection
• The sponsor is responsible for selecting the
investigator(s)/institution(s). Each investigator should
be qualified by training and experience and should
have adequate resources (see 4.1, 4.2) to properly
conduct the trial for which the investigator is selected.
Section 5.18: Monitoring
• In general there is a need for on-site monitoring,
before, during, and after the trial; however in
exceptional circumstances the sponsor may determine
that central monitoring in conjunction with
procedures such as investigators’ training and
meetings, and extensive written guidance can assure
appropriate conduct of the trial in accordance with
GCP.
• Particular attention should be given to those aspects
that are not routine clinical practice and that require
additional training.
7Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
21 CFR Part 11 & 312
Selecting Investigators and Monitors
• (a) Selecting investigators. A
sponsor shall select only
investigators qualified by training
and experience as appropriate
experts to investigate the drug.
Controls for Closed Systems
• (i) Determination that persons who
develop, maintain, or use electronic
record/electronic signature systems
have the education, training, and
experience to perform their assigned
tasks
8Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
When does Training Take Place?
Training of staff at
sites activated
after the live IM
Standardized
training in
advance of formal
Investigator
Meeting(s)
Training of site
staff who did
not attend the
live IM
Training
conducted at
live F2F (or
virtual)
Investigator
Meetings
Training
conducted at
site initiation
visits
Amendment
training
Training of new
site staff (i.e., site
staff turnover)
9Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Types of Training Records
Content
Completion/
Certification
Exemption
Documentation
Standardized (Non
Protocol-specific) Training a a a
Protocol-specific Training a a a
Rater/Scale Training a a a
Vendor/Systems Training a a a
CRA Training at Site
Initiation Visits a a a
Amendment Training a a a
10Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
The TMF Reference
Model
• Site Management  Site Initiation  Site Training
Material
− Training materials used to train the sites. Materials may be related to
Electronic Data Capture (EDC), Interactive Response Technology (IRT),
Rater training. (Also includes training done after site initiation)
• Site Management  Site Set-Up  Site Staff
Qualification Supporting Information
− To document site staff qualifications not previously outlined on CVs.
May include list of studies, publications, training certificates for
specific examinations, ICH-GCP training, site GCP or trial licensure,
medical licenses, Human Subjects Protection Training, etc.
• Site Management  Site Initiation  Site Evidence of
Training
− To document completion of site training by relevant site personnel.
Documentation includes attendance and certification for training
delivered which may include Electronic Data Capture (EDC), Interactive
Response Technology (IRT), Rater training, etc.
• Trial Management  Meetings Trial Team Training
Material
− Trial-relevant training materials , including use of specialized systems.
• Trial Management  Meetings Trial Team Evidence of
Training
− To document completion of trial team training, including certification
or evidence of training (attendance sheets). Includes EDC training.
“Active TMF Management”
12Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Passive vs. Active TMF Operating Models
• Paper documents scanning
• Study teams do not regularly
access the TMF
• TMF is not integrated with
other clinical systems
• No/few manual KPIs or metrics
PASSIVE ACTIVE
• Electronic documents managed
in system
• Sites, CROs, and sponsors
have eTMF access
• TMF is integrated with other
eClinical systems
• Real-time KPIs and metrics
used for active management
13Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Industry Moving to Active eTMF
Industry is moving from a passive model where TMF is considered a cost
center to an active model where TMF is a strategic asset
2.89
4.24
0
1
2
3
4
5
Industry average Average desired state
Passive TMF
“Managed
State”
Docs in system
only after they
are final and
sent, scanned
and processed
Managing the
process
completely in
the system as it
is being
executed
Active TMF
“Optimized
State”
Required
Managed
Effective
Efficient
Optimized
n=50+ unique company evaluations
Source: https://www.veevatmfmaturity.com
14Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
TMF Compliance Challenge and Impact
31%
of inspections over the
past year resulted in
extra days*
DELAYS CAN RESULT IN
$10s OF MILLIONS
IN LOST REVENUE
for a blockbuster product
April 2014 MHRA updated definition of CRITICAL GCP
inspection finding to include INCOMPLETE TMFs
*Trial Master Files; Andy Fischer, MHRA, Senior GCP Inspector; MHRA GCP Symposium, September 2016
“Inspection Readiness”
16Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
What is Inspection
Readiness?
Preparation
Activity
Fire Drill!
State of Being
17Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Where provision of the Trial Master
File (TMF) does not comply with
Regulation 31A 1-3, as the TMF is not
readily available or accessible, or the
TMF is incomplete to such an extent
that it cannot form the basis of
inspection and therefore impedes or
obstructs inspectors carrying out
their duties in verifying compliance
with the Regulations
- MHRA SOP C006/11 “Reporting of
GCP Inspections” 15Apr2014
Completeness
18Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Contemporaneousness
“TMF shall at all times contain the essential documents
relating to that clinical trial”
Journey to
Perpetual Inspection Readiness
20Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
Before 2010: CoE Initiative — Improve Training Based on Feedback from Sites
PROTOCOL AMENDMENT TRAINING
MANUAL USER REQUESTED EXEMPTIONS
LIVE INVESTIGATOR MEETING ATTENDANCE
SIV & SITE VISITS
NON-STANDARDIZED NPS TRACKING
TRAINING VIA CD-ROM & DVD
PAPER STUDY BINDERS
MANUAL ASSET VERSION CONTROL
TRAINING ASSETS MAILED/SHIPPED
21Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2010: Launched Training Portal for Sponsor (NPS & PS Training)
APPROX. 20 ACTIVE STUDIES BY EOY
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
LIVE INVESTIGATOR MEETING ATTENDANCE
PROTOCOL AMENDMENT TRAINING
SIV & SITE VISITS
2010 2011 2013 2015 2017 2018
USER REQUESTED EXEMPTIONS
22Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2011: Cross Study, Cross Sponsor, & User Submitted Exemptions
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
APPROX. 50 ACTIVE STUDIES BY EOY
LIVE INVESTIGATOR MEETING ATTENDANCE
PROTOCOL AMENDMENT TRAINING
SIV & SITE VISITS
2010 2011 2013 2015 20182017
USER REQUESTED EXEMPTIONS with CCD
CROSS STUDY/SPONSOR EXEMPTIONS with CCD
23Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2013: Paper Certificate of Attendance for Live IM Attendance
PROTOCOL AMENDMENT TRAINING
SIV & SITE VISITS
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
USER REQUESTED EXEMPTIONS with CCD
CROSS STUDY/SPONSOR EXEMPTIONS with CCD
LIVE INVESTIGATOR MEETING ATTENDANCE
PAPER COA
2010 2011 2013 2015 20182017
APPROX. 100 ACTIVE STUDIES BY EOY
24Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2015: TransCelerate SIP Integration
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
PROTOCOL AMENDMENT TRAININGS
SIV & SITE VISITS
LIVE INVESTIGATOR MEETING ATTENDANCE
PAPER COA
2010 2011 2013 2015 20182017
TRANSCELERATE SIP INTEGRATION 1.0
USER REQUESTED EXEMPTIONS with CCD
CROSS STUDY/SPONSOR EXEMPTIONS with CCD
APPROX. 150 ACTIVE STUDIES BY EOY
25Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2017: Introduced Interactive Tablet Solution to Live Meetings
INVESTIGATORSPACE LIVE TABLET
PROTOCOL AMENDMENT TRAINING
SIV & SITE VISITS
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
LIVE INVESTIGATOR MEETING ATTENDANCE
PAPER COA
2010 2011 2013 2015 20182017
USER REQUESTED EXEMPTIONS with CCD
CROSS STUDY/SPONSOR EXEMPTIONS with CCD
APPROX. 200 ACTIVE STUDIES BY EOY
26Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
VEEVA VAULT INTEGRATION
PROJECT
2010 2011 2013 2015 20182017
Justification/ROI Execution
27Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
2018: Introduced Mobile App for CRAs to Document Field Training
ON-DEMAND NPS TRAINING
ON-DEMAND PS TRAINING
LIVE INVESTIGATOR MEETING ATTENDANCE
INVESTIGATORSPACE MOBILE PILOT 2018
PROTOCOL AMENDMENT TRAINING
SIV & SITE VISITS
INVESTIGATORSPACE LIVE TABLET PAPER COA
2010 2011 2013 2015 20182017
USER REQUESTED EXEMPTIONS with CCD
CROSS STUDY/SPONSOR EXEMPTIONS with CCD
28Copyright © Veeva Systems 2018
Copyright © Trifecta Clinical 2018
Journey to Perpetual Inspection Readiness
InvestigatorSpace Integrated with Veeva Vault eTMF
Any Questions
Sarah O’Hora — sarah.ohora@veeva.com
Rick Ward — rick.ward@trifectaclinical.com

More Related Content

What's hot

Building a Business Case for Quality Management Transformation
Building a Business Case for Quality Management TransformationBuilding a Business Case for Quality Management Transformation
Building a Business Case for Quality Management Transformation
Veeva Systems
 

What's hot (20)

Demystifying cloud system and validation practices for life sciences
Demystifying cloud system and validation practices for life sciencesDemystifying cloud system and validation practices for life sciences
Demystifying cloud system and validation practices for life sciences
 
Webinar: Driving Operational Agility with Digital Quality Management
Webinar: Driving Operational Agility with Digital Quality ManagementWebinar: Driving Operational Agility with Digital Quality Management
Webinar: Driving Operational Agility with Digital Quality Management
 
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
Improving Clinical Trial Performance: Part 1 - Findings from the Veeva 2018 U...
 
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDCHow ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
 
Using Vault eTMF Milestones and EDLs to Support Inspection Readiness
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessUsing Vault eTMF Milestones and EDLs to Support Inspection Readiness
Using Vault eTMF Milestones and EDLs to Support Inspection Readiness
 
Practical Strategies for Taking on New Studies Post COVID-19
Practical Strategies for Taking on New Studies Post COVID-19Practical Strategies for Taking on New Studies Post COVID-19
Practical Strategies for Taking on New Studies Post COVID-19
 
Improving Clinical Trial Performance: Part 2 - A Unified Approach for Improvi...
Improving Clinical Trial Performance: Part 2 - A Unified Approach for Improvi...Improving Clinical Trial Performance: Part 2 - A Unified Approach for Improvi...
Improving Clinical Trial Performance: Part 2 - A Unified Approach for Improvi...
 
Transforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically DrivenTransforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically Driven
 
Best Practices for Managing Regulatory Binders Electronically
Best Practices for Managing Regulatory Binders ElectronicallyBest Practices for Managing Regulatory Binders Electronically
Best Practices for Managing Regulatory Binders Electronically
 
Steps to Overcome Information Overlaod in Clincial Research
Steps to Overcome Information Overlaod in Clincial ResearchSteps to Overcome Information Overlaod in Clincial Research
Steps to Overcome Information Overlaod in Clincial Research
 
The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder CollaborationThe State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration
 
Implementing a New Clinical Systems Strategy
Implementing a New Clinical Systems StrategyImplementing a New Clinical Systems Strategy
Implementing a New Clinical Systems Strategy
 
Site Connect — The Next Big Step Toward a Collaborative Clinical Ecosystem
Site Connect — The Next Big Step Toward a Collaborative Clinical EcosystemSite Connect — The Next Big Step Toward a Collaborative Clinical Ecosystem
Site Connect — The Next Big Step Toward a Collaborative Clinical Ecosystem
 
Building a Business Case for Quality Management Transformation
Building a Business Case for Quality Management TransformationBuilding a Business Case for Quality Management Transformation
Building a Business Case for Quality Management Transformation
 
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
 
Collaborate Effectively to Transform Clinical Trials
Collaborate Effectively to Transform Clinical TrialsCollaborate Effectively to Transform Clinical Trials
Collaborate Effectively to Transform Clinical Trials
 
2018 Customer Reference Survey Report slides
2018 Customer Reference Survey Report slides2018 Customer Reference Survey Report slides
2018 Customer Reference Survey Report slides
 
GSK: Preparing the Business for Study Start-up Change
GSK: Preparing the Business for Study Start-up ChangeGSK: Preparing the Business for Study Start-up Change
GSK: Preparing the Business for Study Start-up Change
 
Streamline Change Control and Variation Management
Streamline Change Control and Variation ManagementStreamline Change Control and Variation Management
Streamline Change Control and Variation Management
 
Apellis Pharmaceuticals Selects a Modern Safety Solution
Apellis Pharmaceuticals Selects a Modern Safety SolutionApellis Pharmaceuticals Selects a Modern Safety Solution
Apellis Pharmaceuticals Selects a Modern Safety Solution
 

Similar to A Top 20 Pharma’s Journey to Perpetual Inspection Readiness

Clireo eTMF Solution by arivis
Clireo eTMF Solution by arivisClireo eTMF Solution by arivis
Clireo eTMF Solution by arivis
Tricia Campbell - McQuarrie
 
SpiraTest Oversdsadfsfsdfview Presentation.ppt
SpiraTest Oversdsadfsfsdfview Presentation.pptSpiraTest Oversdsadfsfsdfview Presentation.ppt
SpiraTest Oversdsadfsfsdfview Presentation.ppt
MeseAK
 

Similar to A Top 20 Pharma’s Journey to Perpetual Inspection Readiness (20)

Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
Simplifying Postmarket Surveillance: Introducing Veeva Vault Product Surveill...
 
CBI Gain Cross-Industry Insights to Uncover Improvements and Optimize Trial P...
CBI Gain Cross-Industry Insights to Uncover Improvements and Optimize Trial P...CBI Gain Cross-Industry Insights to Uncover Improvements and Optimize Trial P...
CBI Gain Cross-Industry Insights to Uncover Improvements and Optimize Trial P...
 
EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements
 
GTSC Transportation Security Day - Enterprise Support
GTSC Transportation Security Day - Enterprise SupportGTSC Transportation Security Day - Enterprise Support
GTSC Transportation Security Day - Enterprise Support
 
Explore the Implicit Requirements of the NERC CIP RSAWs
Explore the Implicit Requirements of the NERC CIP RSAWsExplore the Implicit Requirements of the NERC CIP RSAWs
Explore the Implicit Requirements of the NERC CIP RSAWs
 
Clireo eTMF Solution by arivis
Clireo eTMF Solution by arivisClireo eTMF Solution by arivis
Clireo eTMF Solution by arivis
 
It32015 slides
It32015 slidesIt32015 slides
It32015 slides
 
Analytical Instrument Qualification - USP chapter 1058 revision
Analytical Instrument Qualification - USP chapter 1058 revisionAnalytical Instrument Qualification - USP chapter 1058 revision
Analytical Instrument Qualification - USP chapter 1058 revision
 
NERC CIP - Top Testing & Compliance Challenges, How to Address Them
NERC CIP - Top Testing & Compliance Challenges, How to Address ThemNERC CIP - Top Testing & Compliance Challenges, How to Address Them
NERC CIP - Top Testing & Compliance Challenges, How to Address Them
 
Last mile assurance training
Last mile assurance trainingLast mile assurance training
Last mile assurance training
 
Unified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov PresentationUnified Clinical Operations - Ennov Presentation
Unified Clinical Operations - Ennov Presentation
 
Operational testing with employee performance tracking for compliance
Operational testing with employee performance tracking for compliance Operational testing with employee performance tracking for compliance
Operational testing with employee performance tracking for compliance
 
Fitman webinar 2015 06 Verification and Validation methodology
Fitman webinar 2015 06 Verification and Validation methodologyFitman webinar 2015 06 Verification and Validation methodology
Fitman webinar 2015 06 Verification and Validation methodology
 
Monitoring As a Service
Monitoring As a ServiceMonitoring As a Service
Monitoring As a Service
 
World quality report 2018 19
World quality report 2018 19World quality report 2018 19
World quality report 2018 19
 
Monitoring and evaluating facility development programs by: Raquel dela Cruz
Monitoring and evaluating facility development programs by: Raquel dela CruzMonitoring and evaluating facility development programs by: Raquel dela Cruz
Monitoring and evaluating facility development programs by: Raquel dela Cruz
 
Continuous Compliance Monitoring
Continuous Compliance MonitoringContinuous Compliance Monitoring
Continuous Compliance Monitoring
 
SpiraTest Oversdsadfsfsdfview Presentation.ppt
SpiraTest Oversdsadfsfsdfview Presentation.pptSpiraTest Oversdsadfsfsdfview Presentation.ppt
SpiraTest Oversdsadfsfsdfview Presentation.ppt
 
Continuous Transaction Monitoring Detect and analyze anomalous transactions t...
Continuous Transaction Monitoring Detect and analyze anomalous transactions t...Continuous Transaction Monitoring Detect and analyze anomalous transactions t...
Continuous Transaction Monitoring Detect and analyze anomalous transactions t...
 
13. Process: ocp cfops site inspections
13. Process: ocp cfops site inspections13. Process: ocp cfops site inspections
13. Process: ocp cfops site inspections
 

More from Veeva Systems

Validation strategies for cloud-based EDCs: more innovation, less effort
Validation strategies for cloud-based EDCs: more innovation, less effortValidation strategies for cloud-based EDCs: more innovation, less effort
Validation strategies for cloud-based EDCs: more innovation, less effort
Veeva Systems
 
Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%
Veeva Systems
 
PICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDCPICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDC
Veeva Systems
 
Best practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standardsBest practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standards
Veeva Systems
 
Designing an EDC System to Work for a CRA
Designing an EDC System to Work for a CRADesigning an EDC System to Work for a CRA
Designing an EDC System to Work for a CRA
Veeva Systems
 

More from Veeva Systems (20)

Strategies and Best Practices for Transforming Enterprise Training
Strategies and Best Practices for Transforming Enterprise TrainingStrategies and Best Practices for Transforming Enterprise Training
Strategies and Best Practices for Transforming Enterprise Training
 
The Industry’s Move Toward Digitally Connected Clinical Trials
The Industry’s Move Toward Digitally Connected Clinical TrialsThe Industry’s Move Toward Digitally Connected Clinical Trials
The Industry’s Move Toward Digitally Connected Clinical Trials
 
Enabling Proactive Quality Management Across Quality and Manufacturing
Enabling Proactive Quality Management Across Quality and ManufacturingEnabling Proactive Quality Management Across Quality and Manufacturing
Enabling Proactive Quality Management Across Quality and Manufacturing
 
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...
 
Moving to unified PV: Transforming Safety with End-to-end PV Solutions
Moving to unified PV: Transforming Safety with End-to-end PV SolutionsMoving to unified PV: Transforming Safety with End-to-end PV Solutions
Moving to unified PV: Transforming Safety with End-to-end PV Solutions
 
Reimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platformReimagine patient safety 2030 governance through a unified safety platform
Reimagine patient safety 2030 governance through a unified safety platform
 
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightReshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and Oversight
 
Tufts Research: EDC Trends, Insights, and Opportunities
Tufts Research: EDC Trends, Insights, and OpportunitiesTufts Research: EDC Trends, Insights, and Opportunities
Tufts Research: EDC Trends, Insights, and Opportunities
 
Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
Tufts Research: Strategies from Data Management Leaders to Speed Clinical TrialsTufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
 
Webinar: Rethinking the Life Sciences Training Technology Ecosystem
Webinar: Rethinking the Life Sciences Training Technology EcosystemWebinar: Rethinking the Life Sciences Training Technology Ecosystem
Webinar: Rethinking the Life Sciences Training Technology Ecosystem
 
Validation strategies for cloud-based EDCs: more innovation, less effort
Validation strategies for cloud-based EDCs: more innovation, less effortValidation strategies for cloud-based EDCs: more innovation, less effort
Validation strategies for cloud-based EDCs: more innovation, less effort
 
Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%Vertex Reduces EDC Study Build Times by 50%
Vertex Reduces EDC Study Build Times by 50%
 
PICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDCPICI’s Best Practices for Building Oncology Studies in an EDC
PICI’s Best Practices for Building Oncology Studies in an EDC
 
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionThe Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution
 
Unify quality manufacturing to drive speed, compliance and collaboration
Unify quality manufacturing to drive speed, compliance and collaborationUnify quality manufacturing to drive speed, compliance and collaboration
Unify quality manufacturing to drive speed, compliance and collaboration
 
Shorten Database Builds by 60% with Agile Design
Shorten Database Builds by 60% with Agile DesignShorten Database Builds by 60% with Agile Design
Shorten Database Builds by 60% with Agile Design
 
Best practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standardsBest practices for implementing and maintaining successful standards
Best practices for implementing and maintaining successful standards
 
Designing an EDC System to Work for a CRA
Designing an EDC System to Work for a CRADesigning an EDC System to Work for a CRA
Designing an EDC System to Work for a CRA
 
Veeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality ImprovementsVeeva Systems Webinar: Driving Continuous Quality Improvements
Veeva Systems Webinar: Driving Continuous Quality Improvements
 
Building a Foundation for Proactive and Predictive Pharmacovigilance
Building a Foundation for Proactive and Predictive PharmacovigilanceBuilding a Foundation for Proactive and Predictive Pharmacovigilance
Building a Foundation for Proactive and Predictive Pharmacovigilance
 

Recently uploaded

Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
Medical / Health Care (+971588192166) Mifepristone and Misoprostol tablets 200mg
 

Recently uploaded (20)

WSO2Con2024 - Enabling Transactional System's Exponential Growth With Simplicity
WSO2Con2024 - Enabling Transactional System's Exponential Growth With SimplicityWSO2Con2024 - Enabling Transactional System's Exponential Growth With Simplicity
WSO2Con2024 - Enabling Transactional System's Exponential Growth With Simplicity
 
WSO2CON 2024 - IoT Needs CIAM: The Importance of Centralized IAM in a Growing...
WSO2CON 2024 - IoT Needs CIAM: The Importance of Centralized IAM in a Growing...WSO2CON 2024 - IoT Needs CIAM: The Importance of Centralized IAM in a Growing...
WSO2CON 2024 - IoT Needs CIAM: The Importance of Centralized IAM in a Growing...
 
%in Soweto+277-882-255-28 abortion pills for sale in soweto
%in Soweto+277-882-255-28 abortion pills for sale in soweto%in Soweto+277-882-255-28 abortion pills for sale in soweto
%in Soweto+277-882-255-28 abortion pills for sale in soweto
 
WSO2CON 2024 - Freedom First—Unleashing Developer Potential with Open Source
WSO2CON 2024 - Freedom First—Unleashing Developer Potential with Open SourceWSO2CON 2024 - Freedom First—Unleashing Developer Potential with Open Source
WSO2CON 2024 - Freedom First—Unleashing Developer Potential with Open Source
 
WSO2CON 2024 - Building the API First Enterprise – Running an API Program, fr...
WSO2CON 2024 - Building the API First Enterprise – Running an API Program, fr...WSO2CON 2024 - Building the API First Enterprise – Running an API Program, fr...
WSO2CON 2024 - Building the API First Enterprise – Running an API Program, fr...
 
WSO2Con2024 - Facilitating Broadband Switching Services for UK Telecoms Provi...
WSO2Con2024 - Facilitating Broadband Switching Services for UK Telecoms Provi...WSO2Con2024 - Facilitating Broadband Switching Services for UK Telecoms Provi...
WSO2Con2024 - Facilitating Broadband Switching Services for UK Telecoms Provi...
 
WSO2Con2024 - WSO2's IAM Vision: Identity-Led Digital Transformation
WSO2Con2024 - WSO2's IAM Vision: Identity-Led Digital TransformationWSO2Con2024 - WSO2's IAM Vision: Identity-Led Digital Transformation
WSO2Con2024 - WSO2's IAM Vision: Identity-Led Digital Transformation
 
WSO2CON 2024 - How CSI Piemonte Is Apifying the Public Administration
WSO2CON 2024 - How CSI Piemonte Is Apifying the Public AdministrationWSO2CON 2024 - How CSI Piemonte Is Apifying the Public Administration
WSO2CON 2024 - How CSI Piemonte Is Apifying the Public Administration
 
WSO2Con204 - Hard Rock Presentation - Keynote
WSO2Con204 - Hard Rock Presentation - KeynoteWSO2Con204 - Hard Rock Presentation - Keynote
WSO2Con204 - Hard Rock Presentation - Keynote
 
WSO2Con2024 - From Blueprint to Brilliance: WSO2's Guide to API-First Enginee...
WSO2Con2024 - From Blueprint to Brilliance: WSO2's Guide to API-First Enginee...WSO2Con2024 - From Blueprint to Brilliance: WSO2's Guide to API-First Enginee...
WSO2Con2024 - From Blueprint to Brilliance: WSO2's Guide to API-First Enginee...
 
What Goes Wrong with Language Definitions and How to Improve the Situation
What Goes Wrong with Language Definitions and How to Improve the SituationWhat Goes Wrong with Language Definitions and How to Improve the Situation
What Goes Wrong with Language Definitions and How to Improve the Situation
 
WSO2CON 2024 - Architecting AI in the Enterprise: APIs and Applications
WSO2CON 2024 - Architecting AI in the Enterprise: APIs and ApplicationsWSO2CON 2024 - Architecting AI in the Enterprise: APIs and Applications
WSO2CON 2024 - Architecting AI in the Enterprise: APIs and Applications
 
WSO2CON 2024 Slides - Open Source to SaaS
WSO2CON 2024 Slides - Open Source to SaaSWSO2CON 2024 Slides - Open Source to SaaS
WSO2CON 2024 Slides - Open Source to SaaS
 
Announcing Codolex 2.0 from GDK Software
Announcing Codolex 2.0 from GDK SoftwareAnnouncing Codolex 2.0 from GDK Software
Announcing Codolex 2.0 from GDK Software
 
WSO2CON 2024 - Navigating API Complexity: REST, GraphQL, gRPC, Websocket, Web...
WSO2CON 2024 - Navigating API Complexity: REST, GraphQL, gRPC, Websocket, Web...WSO2CON 2024 - Navigating API Complexity: REST, GraphQL, gRPC, Websocket, Web...
WSO2CON 2024 - Navigating API Complexity: REST, GraphQL, gRPC, Websocket, Web...
 
WSO2Con2024 - From Code To Cloud: Fast Track Your Cloud Native Journey with C...
WSO2Con2024 - From Code To Cloud: Fast Track Your Cloud Native Journey with C...WSO2Con2024 - From Code To Cloud: Fast Track Your Cloud Native Journey with C...
WSO2Con2024 - From Code To Cloud: Fast Track Your Cloud Native Journey with C...
 
WSO2Con2024 - Unleashing the Financial Potential of 13 Million People
WSO2Con2024 - Unleashing the Financial Potential of 13 Million PeopleWSO2Con2024 - Unleashing the Financial Potential of 13 Million People
WSO2Con2024 - Unleashing the Financial Potential of 13 Million People
 
WSO2CON 2024 - Not Just Microservices: Rightsize Your Services!
WSO2CON 2024 - Not Just Microservices: Rightsize Your Services!WSO2CON 2024 - Not Just Microservices: Rightsize Your Services!
WSO2CON 2024 - Not Just Microservices: Rightsize Your Services!
 
WSO2CON 2024 - Cloud Native Middleware: Domain-Driven Design, Cell-Based Arch...
WSO2CON 2024 - Cloud Native Middleware: Domain-Driven Design, Cell-Based Arch...WSO2CON 2024 - Cloud Native Middleware: Domain-Driven Design, Cell-Based Arch...
WSO2CON 2024 - Cloud Native Middleware: Domain-Driven Design, Cell-Based Arch...
 
Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
Abortion Pill Prices Tembisa [(+27832195400*)] 🏥 Women's Abortion Clinic in T...
 

A Top 20 Pharma’s Journey to Perpetual Inspection Readiness

  • 1. A Top 20 Pharma’s Journey to Perpetual Inspection Readiness
  • 2. 2Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Sarah O’Hora Director Vault Clinical Rick Ward VP, Commercial Operations Leading Today’s Discussion
  • 3. 3Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Discussion Agenda • Defining a few key terms: − “Comprehensive Training Records” − “Active TMF Management“ − “Inspection Readiness” • Top 20 Pharma: Journey to Perpetual Inspection Readiness − Centralizing Training Records Management − Automating Processes − Integrating with eTMF
  • 4. Defining a Few Key Terms
  • 6. 6Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 ICH GCP E6 (R2) Section 4.1: Investigator’s Qualification and Agreements • “The investigator(s) should be qualified by education, training, and experience to assume responsibility for the proper conduct of the trial, should meet all the qualifications specified by the applicable regulatory requirement(s), and should provide evidence of such qualifications through up-to-date curriculum vitae and/or other relevant documentation requested by the sponsor, the IRB/IEC, and/or the regulatory authority(ies).” Section 5.6: Investigator Selection • The sponsor is responsible for selecting the investigator(s)/institution(s). Each investigator should be qualified by training and experience and should have adequate resources (see 4.1, 4.2) to properly conduct the trial for which the investigator is selected. Section 5.18: Monitoring • In general there is a need for on-site monitoring, before, during, and after the trial; however in exceptional circumstances the sponsor may determine that central monitoring in conjunction with procedures such as investigators’ training and meetings, and extensive written guidance can assure appropriate conduct of the trial in accordance with GCP. • Particular attention should be given to those aspects that are not routine clinical practice and that require additional training.
  • 7. 7Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 21 CFR Part 11 & 312 Selecting Investigators and Monitors • (a) Selecting investigators. A sponsor shall select only investigators qualified by training and experience as appropriate experts to investigate the drug. Controls for Closed Systems • (i) Determination that persons who develop, maintain, or use electronic record/electronic signature systems have the education, training, and experience to perform their assigned tasks
  • 8. 8Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 When does Training Take Place? Training of staff at sites activated after the live IM Standardized training in advance of formal Investigator Meeting(s) Training of site staff who did not attend the live IM Training conducted at live F2F (or virtual) Investigator Meetings Training conducted at site initiation visits Amendment training Training of new site staff (i.e., site staff turnover)
  • 9. 9Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Types of Training Records Content Completion/ Certification Exemption Documentation Standardized (Non Protocol-specific) Training a a a Protocol-specific Training a a a Rater/Scale Training a a a Vendor/Systems Training a a a CRA Training at Site Initiation Visits a a a Amendment Training a a a
  • 10. 10Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 The TMF Reference Model • Site Management  Site Initiation  Site Training Material − Training materials used to train the sites. Materials may be related to Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training. (Also includes training done after site initiation) • Site Management  Site Set-Up  Site Staff Qualification Supporting Information − To document site staff qualifications not previously outlined on CVs. May include list of studies, publications, training certificates for specific examinations, ICH-GCP training, site GCP or trial licensure, medical licenses, Human Subjects Protection Training, etc. • Site Management  Site Initiation  Site Evidence of Training − To document completion of site training by relevant site personnel. Documentation includes attendance and certification for training delivered which may include Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training, etc. • Trial Management  Meetings Trial Team Training Material − Trial-relevant training materials , including use of specialized systems. • Trial Management  Meetings Trial Team Evidence of Training − To document completion of trial team training, including certification or evidence of training (attendance sheets). Includes EDC training.
  • 12. 12Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Passive vs. Active TMF Operating Models • Paper documents scanning • Study teams do not regularly access the TMF • TMF is not integrated with other clinical systems • No/few manual KPIs or metrics PASSIVE ACTIVE • Electronic documents managed in system • Sites, CROs, and sponsors have eTMF access • TMF is integrated with other eClinical systems • Real-time KPIs and metrics used for active management
  • 13. 13Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Industry Moving to Active eTMF Industry is moving from a passive model where TMF is considered a cost center to an active model where TMF is a strategic asset 2.89 4.24 0 1 2 3 4 5 Industry average Average desired state Passive TMF “Managed State” Docs in system only after they are final and sent, scanned and processed Managing the process completely in the system as it is being executed Active TMF “Optimized State” Required Managed Effective Efficient Optimized n=50+ unique company evaluations Source: https://www.veevatmfmaturity.com
  • 14. 14Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 TMF Compliance Challenge and Impact 31% of inspections over the past year resulted in extra days* DELAYS CAN RESULT IN $10s OF MILLIONS IN LOST REVENUE for a blockbuster product April 2014 MHRA updated definition of CRITICAL GCP inspection finding to include INCOMPLETE TMFs *Trial Master Files; Andy Fischer, MHRA, Senior GCP Inspector; MHRA GCP Symposium, September 2016
  • 16. 16Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 What is Inspection Readiness? Preparation Activity Fire Drill! State of Being
  • 17. 17Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Where provision of the Trial Master File (TMF) does not comply with Regulation 31A 1-3, as the TMF is not readily available or accessible, or the TMF is incomplete to such an extent that it cannot form the basis of inspection and therefore impedes or obstructs inspectors carrying out their duties in verifying compliance with the Regulations - MHRA SOP C006/11 “Reporting of GCP Inspections” 15Apr2014 Completeness
  • 18. 18Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Contemporaneousness “TMF shall at all times contain the essential documents relating to that clinical trial”
  • 20. 20Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness Before 2010: CoE Initiative — Improve Training Based on Feedback from Sites PROTOCOL AMENDMENT TRAINING MANUAL USER REQUESTED EXEMPTIONS LIVE INVESTIGATOR MEETING ATTENDANCE SIV & SITE VISITS NON-STANDARDIZED NPS TRACKING TRAINING VIA CD-ROM & DVD PAPER STUDY BINDERS MANUAL ASSET VERSION CONTROL TRAINING ASSETS MAILED/SHIPPED
  • 21. 21Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2010: Launched Training Portal for Sponsor (NPS & PS Training) APPROX. 20 ACTIVE STUDIES BY EOY ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING LIVE INVESTIGATOR MEETING ATTENDANCE PROTOCOL AMENDMENT TRAINING SIV & SITE VISITS 2010 2011 2013 2015 2017 2018 USER REQUESTED EXEMPTIONS
  • 22. 22Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2011: Cross Study, Cross Sponsor, & User Submitted Exemptions ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING APPROX. 50 ACTIVE STUDIES BY EOY LIVE INVESTIGATOR MEETING ATTENDANCE PROTOCOL AMENDMENT TRAINING SIV & SITE VISITS 2010 2011 2013 2015 20182017 USER REQUESTED EXEMPTIONS with CCD CROSS STUDY/SPONSOR EXEMPTIONS with CCD
  • 23. 23Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2013: Paper Certificate of Attendance for Live IM Attendance PROTOCOL AMENDMENT TRAINING SIV & SITE VISITS ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING USER REQUESTED EXEMPTIONS with CCD CROSS STUDY/SPONSOR EXEMPTIONS with CCD LIVE INVESTIGATOR MEETING ATTENDANCE PAPER COA 2010 2011 2013 2015 20182017 APPROX. 100 ACTIVE STUDIES BY EOY
  • 24. 24Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2015: TransCelerate SIP Integration ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING PROTOCOL AMENDMENT TRAININGS SIV & SITE VISITS LIVE INVESTIGATOR MEETING ATTENDANCE PAPER COA 2010 2011 2013 2015 20182017 TRANSCELERATE SIP INTEGRATION 1.0 USER REQUESTED EXEMPTIONS with CCD CROSS STUDY/SPONSOR EXEMPTIONS with CCD APPROX. 150 ACTIVE STUDIES BY EOY
  • 25. 25Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2017: Introduced Interactive Tablet Solution to Live Meetings INVESTIGATORSPACE LIVE TABLET PROTOCOL AMENDMENT TRAINING SIV & SITE VISITS ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING LIVE INVESTIGATOR MEETING ATTENDANCE PAPER COA 2010 2011 2013 2015 20182017 USER REQUESTED EXEMPTIONS with CCD CROSS STUDY/SPONSOR EXEMPTIONS with CCD APPROX. 200 ACTIVE STUDIES BY EOY
  • 26. 26Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness VEEVA VAULT INTEGRATION PROJECT 2010 2011 2013 2015 20182017 Justification/ROI Execution
  • 27. 27Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness 2018: Introduced Mobile App for CRAs to Document Field Training ON-DEMAND NPS TRAINING ON-DEMAND PS TRAINING LIVE INVESTIGATOR MEETING ATTENDANCE INVESTIGATORSPACE MOBILE PILOT 2018 PROTOCOL AMENDMENT TRAINING SIV & SITE VISITS INVESTIGATORSPACE LIVE TABLET PAPER COA 2010 2011 2013 2015 20182017 USER REQUESTED EXEMPTIONS with CCD CROSS STUDY/SPONSOR EXEMPTIONS with CCD
  • 28. 28Copyright © Veeva Systems 2018 Copyright © Trifecta Clinical 2018 Journey to Perpetual Inspection Readiness InvestigatorSpace Integrated with Veeva Vault eTMF
  • 30. Sarah O’Hora — sarah.ohora@veeva.com Rick Ward — rick.ward@trifectaclinical.com

Editor's Notes

  1. < < < PLACEHOLDER WHILE WE WAIT FOR PRESENTATION TO BEGIN > > >
  2. SARAH: Introduction, Thank you, etc… RICK: Hello everyone – my name is Rick Ward and I head up Commercial Operations for Trifecta Clinical. Before we get started I’d like to note tha the views I share today are my own and not those of Trifecta Clinical. With that said, I’m very excited to be joining Sarah today to share what we believe will be a very interesting case study and hopefully provide everyone with some ideas they can bring back to their respective organizations.
  3. SARAH: Define a few key terms to level set the discussion… RICK: Share how Veeva and Trifecta partnered to build an integrated solution and helped a Top 20 Pharma company achieve, and perpetually maintain a state of Inspection Readiness.
  4. First…
  5. SARAH: x RICK: Key concept = There are well defined regulatory requirements to provide, and document, appropriate training of Investigators and Site Staff.
  6. SARAH: x
  7. RICK: Before we further define the types of “training records” which exist, let’s recognize that throughout the life cycle of a clinical trial, training takes place at different points in time, in various forms. And documentation (if it exists) is often decentralized in both paper and electronic formats (records from F2F IM, virtual IM logs, monitoring trip reports, etc.).
  8. RICK: So in addition to the various types of training, which include “general” or “standardized” training, sometimes referred to as “Non Protocol-Specific” training (things like ICH/GCP training, safety reporting, etc.), detailed training specific to the study protocol. And all too often we also have amendment training which could take place well after the study is launched. But in defining the term “Training Records” we need to keep in mind that this is not limited to the training content itself, but also compliance documentation that the training was completed by all required parties (often referred to as “training certification”), as well as documentation of any training exemptions granted. And again, with this documentation being generated throughout the study, and historically created in both paper and electronic format, often in a very decentralized model, it’s clear that being “Inspection Ready” with regards to Training Documentation can be quite a challenge.
  9. SARAH: x (good segue from “training documentation” to “active TMF Management”)
  10. SARAH: x
  11. SARAH: x
  12. SARAH: x
  13. SARAH: x
  14. RICK: Thank you Sarah, I think we’re all on the same page now regarding what it means to Actively Manage the Trial Master File. Before we begin telling the story of how a Top-20 Pharma …
  15. SARAH: x
  16. SARAH: x
  17. SARAH: x (will end with reference to “automating processes”)
  18. RICK: x
  19. RICK: Prior to Trifecta’s involvement, the sponsor was in a situation typical for that time. Investigator training processes and procedures were defined centrally, but conducted using assets that largely fell on individual study teams and site startup personnel to provide. Lack of a centralized training database could result in duplicative training being conducted by site personnel, and required sponsor teams spend a great deal of effort distributing the training assets. Gathering training records manually was also very time intensive. This situation was frustrating for both sites and sponsor teams alike, which is why investigator training was identified as a Center of Excellence initiative.
  20. RICK: Starting in 2010, Trifecta worked with the CoE to create an on-demand NPS training library. In addition, Trifecta would produce protocol specific training by capturing live investigator meetings for site personnel who could not attend. Training was launched using Trifecta’s first generation SaaS training portal, and the process of onboarding studies began. The core benefits of having single point of distribution, combined with centralized and normalized training history data provided immediate benefits to the sponsor and sites.
  21. RICK: In year two, as adoption accelerated, programs with a second study launching on the platform became more prevalent. Responding to site feedback, the sponsor asked if Trifecta could help sites working on multiple studies avoid duplicate training. The sponsor’s training leadership and Trifecta collaborated to create the Compliance & Certification Directory. The CCD is a sub-system that accurately identifies users across studies, then applies training equivalency rules to create study specific exemption documentation. The CCD would continue to grow: it currently processes nearly 60,000 individual exemptions per year.
  22. RICK: While online training processes were now efficient, reconciliation of live investigator training attendance continued to be labor intensive. In early 2013, Trifecta and the sponsor collaborated on the creation of the Certificate of Attendance (COA) system. COA had three major components; an Investigator Meeting Agenda creation system that provided consistent training topics naming across both online and live training events; a sign-in sheet generation system that used NPS data to create session sign in sheets (for example, a morning and afternoon session); and finally, the sign-in sheets themselves which include a quick-code containing all attendee information for that user and session. Once the sheet was signed, these code linked all elements to allow for the systematic reporting of live meeting training credit. Further, since live training and online training were now linked, novel use cases were now possible. For example, if a coordinator left a two-day IM early on the second day, they would automatically be sent a welcome email in order to complete the training topics provided during the session they missed
  23. RICK: As the sponsor is an early adopter of the Transclerate shared investigator portal, Trifecta worked with the sponsor and SIP stakeholders to complete the initial integration between Trifecta’s InvestigatorSpace training system and the Transclerate Shared Investigator Portal. Once a SIP user logs into the SIP using their Exostar credentials, they can click a SAML-based, single-sign-on link taking them seamlessly from the SIP into InvestigatorSpace. Once in InvestigatorSpace, training exemptions are processed, either from online sources or the COA system, then the users begin training. While taking training, the user’s training progress is sent back to the SIP in REAL TIME, ensuring training completion is always synchronized from InvestigatorSpace to the SIP.
  24. RICK: Building on the hybrid integration model of the paper COA, Trifecta was approached do create and tablet solution for live meetings that would provide an IS Live, an extension of InvestigatorSpace in the form of an interactive tablet solution, not only boosted the level of attendee engagement, but also allowed for the automated documentation of in-person training. NOTE: Coming back to 2017 in a moment!!!
  25. RICK: While Trifecta continued to automate the upstream training processes, inserting technology to capture data from training processes in near-realtime, it was not until the integration with Veeva Vault that the promise of Perpetual inspection readiness became truly possible. For the sponsor, the project had considerable ROI independent of this etc. etc. 248k x 3 min = x years of effort saved. From a project execution perspective, the sponsor provided all needed technical resourses, Veeva expert guidance and support, allowing the integration to be completed 12 days ahead of schedule. This year, in even though this pharma company was likely the industry leader in “Inspection Readiness”, at least with respect to training records, there was still a perceived “gap” of centrally tracking the training that takes place at SIVs as well as any other “field training” conducted by CRA’s. Thus, IS Mobile was developed to capture real-time documentation of any training discussions that take place at the site.
  26. RICK: Now that Live meeting attendance had been fully automated with IS Live, there was one final process, etc., - training conducted between a monitor or other field personnel and at the site location. While this will be piloted later this year, InvestigatorSpace mobile for Android and iOS allows for…etc. etc. This year, in even though this pharma company was likely the industry leader in “Inspection Readiness”, at least with respect to training records, there was still a perceived “gap” of centrally tracking the training that takes place at SIVs as well as any other “field training” conducted by CRA’s. Thus, IS Mobile was developed to capture real-time documentation of any training discussions that take place at the site.
  27. Single source of truth, summary. Path has been paved TWO PREPARED QUESTIONS:
  28. Staged Questions: Rick – “Is the integration between Trifecta’s system and Veeva Vault eTMF available to anyone and how long does it take to implement?” Sarah – “Do you provide “best practices” in how to structure your eTMF and what training documentation should be included?” Rick – “??? Sarah – “???
  29. SARAH: Just want to thank everyone again for sharing your time with us ……. RICK: Also, thank you all for the terrific questions. We did not get to every one, but we will follow up with folks directly on all the questions submitted. Additionally, if anyone has additional questions please feel free to reach out to either of us directly at any time. Thank you again!